Bogdan Ivanišević, co-head of BDK’s Life Sciences and Healthcare sector group, and Slobodan Trivić, associate in the group, wrote an article for the Experts Review section in June 2015 issue of CEE Legal Matters. The article is entitled “Approach to Regulatory Issues in Serbian Pharmaceutical M&A”.
The article is currently provided to subscribers only; it will become accessible to non-subscribers two months after the publication.
